Power Law company profile

Kelonia Therapeutics

Biotech & Life Sciences · Boston, United States · Founded 2020 Unicorn

Developing a new wave of genetic medicines using its next generation vivo gene delivery platform

Valuation

$2.5–5B

Latest valuation · Apr/2026

Unlock exact value

Headcount

<100

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

3 investors on Kelonia Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage

Alta Partners

Venrock

Horizons Ventures

Global footprint

Where Kelonia Therapeutics has talent and traffic

Workforce by country

🇺🇸 United States · Boston HQ

Book a demo for the full country breakdown

Web traffic by country

6.1K monthly visits
across markets

🇺🇸 United States67.2%

🇦🇺 Australia31.1%

Top 2 markets shown

Market sentiment

What the market is saying about Kelonia Therapeutics

An AI-synthesized read of the highest-engagement posts about Kelonia Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Kelonia Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles